Showing 34,805 results

Filters
New & experimental hepatitis C treatment

European CHMP Adopts Positive Opinion for Gilead’s Harvoni® (Ledipasvir/Sofosbuvir) for the Treatment of Chronic Hepatitis C Infection in Adults

Editor's pick
Gilead press release
29 September 2014
Cancer

Nearly half of HIV-positive gay men could benefit from being vaccinated against HPV, say Irish researchers

News
29 September 2014
PrEP

Can this HIV drug help to end 30 years of blighted lives?

Editor's pick
The Guardian
29 September 2014
New & experimental HIV treatments

Doctor treats Ebola with HIV drug in Liberia - seemingly successfully

Editor's pick
CNN
27 September 2014
Dating, relationships & feelings

Choosing to Love Poz Guys

Editor's pick
Betablog
27 September 2014
Access to healthcare

Countries ready to “Fast Track” response to end the AIDS epidemic by 2030

Editor's pick
UNAIDS
26 September 2014
HIV & criminal law

Sweden: Supreme Court refuses to rule on treatment’s impact on HIV risk

Editor's pick
HIV Justice Network
26 September 2014
Access to healthcare

Roche launches Global Access Program for HIV viral load testing

Editor's pick
Roche press release
26 September 2014
Health monitoring in resource-limited settings

Treatment of worm infections leads to increases in CD4 counts and haemoglobin and fall in viral load for HIV-positive women taking ART

News
26 September 2014
New & experimental HIV treatments

Tybost (Cobicistat) and Vitekta (Elvitegravir) Approved by FDA as Individual HIV Drugs

Editor's pick
The Body
26 September 2014
PrEP

PrEP, The Pill, and the Fear of Promiscuity

Editor's pick
Nursing Clio
25 September 2014
PrEP

Truvada: 'Honestly, it's a revolution. It's so great taking control'

Editor's pick
The Guardian
25 September 2014
Global health initiatives

Hard choices in Russia as the final HIV grant proposal is submitted

Editor's pick
Aidspan
25 September 2014
Vaginal rings & topical PrEP

Give Some LOVE to IRMA for Give OUT Day

Editor's pick
IRMA
25 September 2014
New & experimental HIV treatments

Gilead’s investigational tenofovir alafenamide (TAF)-based single tablet HIV regimen meets 48-week primary objective in two Phase 3 studies

Editor's pick
Gilead press release
25 September 2014
Global health initiatives

Russia's harm reduction programs threatened by want of funds

Editor's pick
Global Fund Observer
25 September 2014
Hepatitis C treatment

Why Gilead’s Recent Deal with Generic Producers for its Hepatitis C Drugs (Sofosbuvir and Ledipasvir) is a Sham

Editor's pick
ITPC
25 September 2014
Hepatitis C treatment

NICE consults on draft guidance on the drug simeprevir (Olysio) for treating hepatitis C

Editor's pick
NICE
25 September 2014
New & experimental HIV treatments

Gilead's Latest HIV Pill Meets Study Goals

Editor's pick
Wall Street Journal
24 September 2014
Epidemiology & behaviour

London gay men: 2% of the population, a quarter of the sexually transmitted infections and half of HIV infections

News
24 September 2014
UK health services

Dr Steve Taylor: Why Privatisation Is Killing the NHS

Editor's pick
Huffington Post
24 September 2014
Opportunistic infections

Fungus Behind AIDS Deaths Found Growing on Trees in Southern California

Editor's pick
Science Speaks
24 September 2014
Bad science & bogus treatments

HIV Research Fraud Highlights Scramble for Federal Science Grant Money

Editor's pick
Science Speaks
24 September 2014
Hepatitis C treatment

As Gilead Mulls Price of Next Hepatitis C Drug, Top Activist Refutes "Bogus" Math

Editor's pick
TheBody.com
24 September 2014